Anti-DHI1L/ HSD11B1L/ 11-DH3 functional antibody

Anti-DHI1L/ HSD11B1L/ 11-DH3 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to HSD11B1L/HSD11B1L products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0269-Ab-1/ GM-Tg-hg-SE0269-Ab-2Anti-Human HSD11B1L monoclonal antibodyHuman
GM-Tg-rg-SE0269-Ab-1/ GM-Tg-rg-SE0269-Ab-2Anti-Rat HSD11B1L monoclonal antibodyRat
GM-Tg-mg-SE0269-Ab-1/ GM-Tg-mg-SE0269-Ab-2Anti-Mouse HSD11B1L monoclonal antibodyMouse
GM-Tg-cynog-SE0269-Ab-1/ GM-Tg-cynog-SE0269-Ab-2Anti-Cynomolgus/ Rhesus macaque HSD11B1L monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0269-Ab-1/ GM-Tg-felg-SE0269-Ab-2Anti-Feline HSD11B1L monoclonal antibodyFeline
GM-Tg-cang-SE0269-Ab-1/ GM-Tg-cang-SE0269-Ab-2Anti-Canine HSD11B1L monoclonal antibodyCanine
GM-Tg-bovg-SE0269-Ab-1/ GM-Tg-bovg-SE0269-Ab-2Anti-Bovine HSD11B1L monoclonal antibodyBovine
GM-Tg-equg-SE0269-Ab-1/ GM-Tg-equg-SE0269-Ab-2Anti-Equine HSD11B1L monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0269-Ab-1/ GM-Tg-hg-SE0269-Ab-2; GM-Tg-rg-SE0269-Ab-1/ GM-Tg-rg-SE0269-Ab-2;
GM-Tg-mg-SE0269-Ab-1/ GM-Tg-mg-SE0269-Ab-2; GM-Tg-cynog-SE0269-Ab-1/ GM-Tg-cynog-SE0269-Ab-2;
GM-Tg-felg-SE0269-Ab-1/ GM-Tg-felg-SE0269-Ab-2; GM-Tg-cang-SE0269-Ab-1/ GM-Tg-cang-SE0269-Ab-2;
GM-Tg-bovg-SE0269-Ab-1/ GM-Tg-bovg-SE0269-Ab-2; GM-Tg-equg-SE0269-Ab-1/ GM-Tg-equg-SE0269-Ab-2
Products NameAnti-HSD11B1L monoclonal antibody
Formatmab
Target NameHSD11B1L
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-HSD11B1L benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0269-Ag-1Recombinant multi-species DHI1L/ HSD11B1L/ 11-DH3 protein


    Target information

    Target IDGM-SE0269
    Target NameHSD11B1L
    Gene ID374875,696612,485027,101092746,404546,100147231
    Gene Symbol and Synonyms11-beta-HSD3,11-DH3,HSD11B1L,HSD1L,HSD3,SCDR10,SCDR10B,SDR26C2
    Uniprot AccessionQ7Z5J1,Q6Q7D1
    Uniprot Entry NameDHI1L_HUMAN,DHI1L_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000167733
    Target ClassificationN/A

    The target: HSD11B1L, gene name: HSD11B1L, also named as 11-DH3, 11-beta-HSD3, HSD3, SCDR10, SCDR10B, SDR26C2. This gene is a member of the hydroxysteroid dehydrogenase family. The encoded protein is similar to an enzyme that catalyzes the interconversion of inactive to active glucocorticoids (e.g. cortisone). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.